This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
In a digital era, the increasing dependence on screens and technology particularly among gamers is prolonging exposure to blue light. Madrid-based nutraceutical experts Pharmactive Biotech Products S.L.’s offers its proprietary affronEYE® saffron ingredient, a fast-absorbing antioxidant that can potentially address the negative impacts of blue-light exposure including Gamer Eye Syndrome and provide overall support to eye health.
The study, published in the International Journal of Molecular Sciences on August 2019 was led by Jose Fernandez-Albarral, PhD, of the Complutense University of Madrid, demonstrated the neuroprotective and anti-inflammatory effects of Pharmactive’s proprietary hydrophilic saffron extract (standardized to 3% crocin content) in a mouse model of unilateral, laser-induced ocular hypertension (OHT).
Affron is standardized to Lepticrosalides®, a complex of bioactive compounds responsible for the beneficial and organoleptic attributes of Affron. The capabilities of this clean-label, synthetic-free, pure plant saffron extract is backed by several clinical studies.
A new study has found that saffron, a commonly used spice that add flavor and color to foods, provides a significant chemo-preventive effect against liver cancer in animal models.